Recent patient studies surrounding the medication Retatrutide , specifically the 120mg formulation branded as ZPHC, suggest a considerable benefit on weight decrease and associated health conditions . Experts posit that this combined agonist , influencing both GLP-1 and GIP receptors , has the po